Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial

Krista A Varady, Surabhi Bhutani, Monica C Klempel, Cynthia M Kroeger, John F Trepanowski, Jacob M Haus, Kristin K Hoddy, Yolian Calvo, Krista A Varady, Surabhi Bhutani, Monica C Klempel, Cynthia M Kroeger, John F Trepanowski, Jacob M Haus, Kristin K Hoddy, Yolian Calvo

Abstract

Background: Alternate day fasting (ADF; ad libitum "feed day", alternated with 25% energy intake "fast day"), is effective for weight loss and cardio-protection in obese individuals. Whether these effects occur in normal weight and overweight individuals remains unknown. This study examined the effect of ADF on body weight and coronary heart disease risk in non-obese subjects.

Methods: Thirty-two subjects (BMI 20-29.9 kg/m2) were randomized to either an ADF group or a control group for 12 weeks.

Results: Body weight decreased (P < 0.001) by 5.2 ± 0.9 kg (6.5 ± 1.0%) in the ADF group, relative to the control group, by week 12. Fat mass was reduced (P < 0.001) by 3.6 ± 0.7 kg, and fat free mass did not change, versus controls. Triacylglycerol concentrations decreased (20 ± 8%, P < 0.05) and LDL particle size increased (4 ± 1 Å, P < 0.01) in the ADF group relative to controls. CRP decreased (13 ± 17%, P < 0.05) in the ADF group relative to controls at week 12. Plasma adiponectin increased (6 ± 10%, P < 0.01) while leptin decreased (40 ± 7%, P < 0.05) in the ADF group versus controls by the end of the study. LDL cholesterol, HDL cholesterol, homocysteine and resistin concentrations remained unchanged after 12 weeks of treatment.

Conclusion: These findings suggest that ADF is effective for weight loss and cardio-protection in normal weight and overweight adults, though further research implementing larger sample sizes is required before solid conclusion can be reached.

Figures

Figure 1
Figure 1
Study flow chart. ADF: Alternate day fasting.
Figure 2
Figure 2
Body weight and body composition changes at week 12. Values reported as mean ± SEM. ADF: Alternate day fasting. *Body weight and fat mass significantly different (P < 0.001) from the control group at week 12 (Independent samples t-test). No difference between groups for fat free mass at week 12 (Independent samples t-test).

References

    1. Varady KA, Hellerstein MK. Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr. 2007;86:7–13.
    1. Varady KA, Bhutani S, Church EC, Klempel MC. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr. 2009;90:1138–1143. doi: 10.3945/ajcn.2009.28380.
    1. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metabolism. 2013;62:137–143. doi: 10.1016/j.metabol.2012.07.002.
    1. Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Varady KA. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity (Silver Spring) 2013. Epub ahead of print.
    1. Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005;81:69–73.
    1. Halberg N, Henriksen M, Söderhamn N, Stallknecht B, Ploug T, Schjerling P, Dela F. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol. 2005;99:2128–2136. doi: 10.1152/japplphysiol.00683.2005.
    1. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990;51:241–247.
    1. Gidding SS, Lichtenstein AH, Faith MS, Karpyn A, Mennella JA, Popkin B, Rowe J, Van Horn L, Whitsel L. Implementing American heart association pediatric and adult nutrition guidelines: a scientific statement from the American heart association nutrition committee of the council on nutrition, physical activity and metabolism, council on cardiovascular disease in the young, council on arteriosclerosis, thrombosis and vascular biology, council on cardiovascular nursing, council on epidemiology and prevention, and council for high blood pressure research. Circulation. 2009;119:1161–1175. doi: 10.1161/CIRCULATIONAHA.109.191856.
    1. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000;24:38–48. doi: 10.1038/sj.ijo.0801083.
    1. Chung M, Lichtenstein AH, Ip S, Lau J, Balk EM. Comparability of methods for LDL subfraction determination: a systematic review. Atherosclerosis. 2009;205:342–348. doi: 10.1016/j.atherosclerosis.2008.12.011.
    1. Varady KA, Lamarche B. Lipoprint adequately estimates LDL size distribution, but not absolute size, versus polyacrylamide gradient gel electrophoresis. Lipids. 2011;46:1163–1167. doi: 10.1007/s11745-011-3611-8.
    1. Klempel MC, Bhutani S, Fitzgibbon M, Freels S, Varady KA. Dietary and physical activity adaptations to alternate day modified fasting: implications for optimal weight loss. Nutr J. 2010;9:35. doi: 10.1186/1475-2891-9-35.
    1. Bhutani S, Klempel MC, Kroeger CM, Aggour E, Calvo Y, Trepanowski JF, Hoddy KK, Varady KA. Effect of exercising while fasting on eating behaviors and food intake. J Int Soc Sports Nutr. 2013;10(1):50. doi: 10.1186/1550-2783-10-50.
    1. Varady KA, Bhutani S, Klempel MC, Lamarche B. Improvements in LDL particle size and distribution by short-term alternate day modified fasting in obese adults. Br J Nutr. 2011;105:580–583. doi: 10.1017/S0007114510003788.
    1. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting increases LDL particle size independently of dietary fat content in obese humans. Eur J Clin Nutr. 2013. Epub ahead of print.
    1. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56:320–328.
    1. Ryan AS, Nicklas BJ. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care. 2004;27:1699–1705. doi: 10.2337/diacare.27.7.1699.
    1. Jae SY, Fernhall B, Heffernan KS. et al.Effects of lifestyle modifications on C-reactive protein: contribution of weight loss and improved aerobic capacity. Metabolism. 2006;55:825–831. doi: 10.1016/j.metabol.2006.02.010.
    1. Kris-Etherton P, Eckel RH, Howard BV, St Jeor S, Bazzarre TL. Nutrition committee population science committee and clinical science committee of the American heart association. AHA science advisory: Lyon diet heart study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I dietary pattern on cardiovascular disease. Circulation. 2001;103:1823–1825. doi: 10.1161/01.CIR.103.13.1823.
    1. Schwingshackl L, Hoffmann G. Low-carbohydrate diets and cardiovascular risk factors. Obes Rev. 2013;14:183–184. doi: 10.1111/j.1467-789X.2012.01060.x.
    1. Scagliusi FB, Ferriolli E, Pfrimer K, Laureano C, Cunha CS, Gualano B, Lourenço BH, Lancha AH Jr. Characteristics of women who frequently under report their energy intake: a doubly labelled water study. Eur J Clin Nutr. 2009;63:1192–1199. doi: 10.1038/ejcn.2009.54.
    1. Nielsen BM, Nielsen MM, Toubro S, Pedersen O, Astrup A, Sørensen TI, Jess T, Heitmann BL. Past and current body size affect validity of reported energy intake among middle-aged Danish men. J Nutr. 2009;139:2337–2343. doi: 10.3945/jn.109.112599.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다